Clinical Trials Browser

Glioblastoma × Anti-Bacterial Agents × Clear all

NCT01967758 2018-08-17

Phase I Study of Safety and Immunogenicity of ADU-623

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma